- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 27.12M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 165.71M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 1.08M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.32M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $18.41M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.96M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $138.83M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$631.82M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $6.17M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$129K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.58M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.14M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $40.92M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $640.5M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $19.05M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $8.68M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $179.74M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.04M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $3.33 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $7.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $21.23 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $7.22 |
| Net Income | Q1 2026 · Mar 31, 2026 | $552.4M |
| Net Income | Q1 2026 · Mar 31, 2025 | $7.67M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $22.29M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.29M |